DK

Dhirendra Kumar Gupta

Active Director Director DIN 10254078
DIN 10254078 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Dhirendra Kumar Gupta

Data last updated:

Dhirendra Kumar Gupta is a Director at Ropana Biotech Private Limited (since 2023). Ropana Biotech Private Limited reported revenue of ₹1,518 (FY 2025).

DIN 10254078
Primary Designation Director
First Appointment 25 Jul 2023
Oldest Company Age 3 yrs
Largest company Ropana Biotech Private Limited · ₹1,518 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ropana Biotech Private Limited U46497UP2023PTC186270
Director25 Jul 20232023₹1,518 (FY 2025)Active

Board colleagues of Dhirendra Kumar Gupta

NameDINCompanyDesignation
Yashdeep Gupta10254079Ropana Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ropana Biotech Private Limited
Premium access

Shareholding and investment profile for Dhirendra Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhirendra Kumar Gupta

Dhirendra Kumar Gupta currently holds 1 directorship: Ropana Biotech Private Limited (Director, since 25 Jul 2023, revenue ₹1,518 (FY 2025)).

Dhirendra Kumar Gupta was first appointed on 25 Jul 2023 as Director at Ropana Biotech Private Limited.

The current boards of Dhirendra Kumar Gupta's companies include Yashdeep Gupta (Ropana Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available